Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells.

× No keyword cloud information.

8 in total

1. The insulin glargine dilemma: an opportunity for the diabetes community?

Authors: M Stumvoll; P P Nawroth
Journal: Diabetologia Date: 2009-08-14 Impact factor: 10.122

2. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death.

Authors: L P Weng; O Gimm; J B Kum; W M Smith; X P Zhou; D Wynford-Thomas; G Leone; C Eng
Journal: Hum Mol Genet Date: 2001-02-01 Impact factor: 6.150

3. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.

Authors: C J Guigon; L Zhao; M C Willingham; S-Y Cheng
Journal: Oncogene Date: 2008-11-10 Impact factor: 9.867

4. FOXO3a: a novel player in thyroid carcinogenesis?

Authors: Stefan Karger; Carl Weidinger; Kerstin Krause; Sien-Yi Sheu; Thomas Aigner; Oliver Gimm; Kurt-Werner Schmid; Henning Dralle; Dagmar Fuhrer
Journal: Endocr Relat Cancer Date: 2008-10-09 Impact factor: 5.678

5. Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.

Authors: J M Jonasson; R Ljung; M Talbäck; B Haglund; S Gudbjörnsdòttir; G Steineck
Journal: Diabetologia Date: 2009-07-09 Impact factor: 10.122

Review 6. Forkhead box-O transcription factor: critical conductors of cancer's fate.

Authors: Carl Weidinger; Kerstin Krause; Antje Klagge; Stefan Karger; Dagmar Fuhrer
Journal: Endocr Relat Cancer Date: 2008-09-05 Impact factor: 5.678

7. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

Authors: Ashish Shukla; Jean Grisouard; Volker Ehemann; Alexander Hermani; Harald Enzmann; Doris Mayer
Journal: Endocr Relat Cancer Date: 2009-01-19 Impact factor: 5.678

Review 8. Molecular biology of thyroid cancer initiation.

Authors: G Riesco-Eizaguirre; P Santisteban
Journal: Clin Transl Oncol Date: 2007-11 Impact factor: 3.405

8 in total

6 in total

1. Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years.

Authors: Haim Werner; Ernst A Chantelau
Journal: Diabetol Metab Syndr Date: 2011-06-29 Impact factor: 3.320

2. Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.

Authors: Jingxuan Pan; Chun Chen; Yanli Jin; Enrique Fuentes-Mattei; Guermarie Velazquez-Tores; Juliana Maria Benito; Marina Konopleva; Michael Andreeff; Mong-Hong Lee; Sai-Ching Jim Yeung
Journal: Cell Cycle Date: 2012-06-15 Impact factor: 4.534

3. Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.

Authors: Xulei Tang; Lin Yang; Zhiyu He; Jingfang Liu
Journal: PLoS One Date: 2012-12-19 Impact factor: 3.240

Review 4. Cancer biology in diabetes.

Authors: Shi Sen; Yanzheng He; Daisuke Koya; Keizo Kanasaki
Journal: J Diabetes Investig Date: 2014-03-05 Impact factor: 4.232

Review 5. Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer.

Authors: Yevgeniya Kushchayeva; Sergiy Kushchayev; Kirk Jensen; Rebecca J Brown
Journal: Cancers (Basel) Date: 2022-01-22 Impact factor: 6.639

6. Insulin therapy and cancer in type 2 diabetes.

Authors: Edoardo Mannucci
Journal: ISRN Endocrinol Date: 2012-11-14

6 in total